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B and T lymphocytes, the primary cells of the 
adaptive immune system, provide a major line 
of defense against foreign molecules by virtue 
of vastly diverse antigen-specific receptors. The 
variable regions of antigen receptor genes are 
assembled from numerous V (variable), D (di-
versity), and J (joining) coding segments, which 
are cut and pasted together in a multitude of 
combinations via the programmed DNA rear-
rangement V(D)J recombination (1, 2). This 
process occurs during early lymphocyte devel-
opment and is required for progenitors to ma-
ture into functional B and T lymphocytes. V(D)J 
recombination is initiated by the recombination 
activating gene (RAG) 1 and 2 proteins, which 
comprise an endonuclease that recognizes spe-
cific recombination signal sequences (RSSs) adja-
cent to each V, D, and J segment. The RAG1/2 
endonuclease induces DNA double-strand breaks 
(DSBs) between the RSSs and coding segments 
(2–4) and generates ends with two distinct struc-
tures: 5 phosphorylated blunt RS ends and co-
valently closed hairpin coding ends. Joining of 
the RAG1/2-generated DNA breaks requires 
the ubiquitously expressed nonhomologous end- 
joining (NHEJ) DNA repair factors, which in-
clude Ku70, Ku80, the DNA-dependent protein 
kinase catalytic subunit (DNA-PKcs), XRCC4, 
DNA ligase IV (Lig4), Cernunnos/XLF, and 
Artemis (1, 2, 5, 6). The NHEJ factors also play 
critical roles in general DSB repair and main-
taining genome stability.
Artemis possesses intrinsic 5 to 3 single-
strand exonuclease activity and becomes activated 
as an endonuclease when complexed with DNA-
PKcs (7). Artemis–DNA-PKcs nicks the cova-
lently closed coding ends, and hairpin opening at 
variable positions away from the apex, followed   
by fill-in synthesis, leads to addition of palin-
dromic “P” nucleotides. Together, these end-
processing steps further diversify the antigen 
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Artemis was initially discovered as the gene inactivated in human radiosensitive TB severe 
combined immunodeficiency, a syndrome characterized by the absence of B and T lympho-
cytes and cellular hypersensitivity to ionizing radiation. Hypomorphic Artemis alleles have 
also been identified in patients and are associated with combined immunodeficiencies of 
varying severity. We examine the molecular mechanisms underlying a syndrome of partial 
immunodeficiency caused by a hypomorphic Artemis allele using the mouse as a model 
system. This mutation, P70, leads to premature translation termination that deletes a large 
portion of a nonconserved C terminus. We find that homozygous Artemis-P70 mice exhibit 
reduced numbers of B and T lymphocytes, thereby recapitulating the patient phenotypes. The 
hypomorphic mutation results in impaired end processing during the lymphoid-specific DNA 
rearrangement known as V(D)J recombination, defective double-strand break repair, and 
increased chromosomal instability. Biochemical analyses reveal that the Artemis-P70 mutant 
protein interacts with the DNA-dependent protein kinase catalytic subunit and retains 
significant, albeit reduced, exo- and endonuclease activities but does not undergo phosphory-
lation. Together, our findings indicate that the Artemis C terminus has critical in vivo  
functions in ensuring efficient V(D)J rearrangements and maintaining genome integrity.
© 2009 Huang et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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combined molecular, cellular, and biochemical approaches. 
The results of our studies provide insights into the mecha-
nisms that underlie partial immunodeficiency in patients that 
harbor this hypomorphic allele. In addition, our findings reveal 
important in vivo functions of the Artemis C terminus in gen-
eral DNA DSB repair and maintenance of genomic stability.
RESULTS
Development of a mouse model of human  
partial immunodeficiency
We generated a mouse model harboring the hypomorphic   
Artemis-P70 allele within the endogenous locus via targeted 
mutation. The P70 allele is a 7-nt deletion that results in a 
frameshift at D451 (D449 of the mouse Artemis protein) fol-
lowed by a premature stop codon 10 aa downstream (15). To 
model the P70 mutation within the mouse genomic locus, we 
introduced a nonsense mutation to substitute a stop codon for 
the aspartate at position 449 (of 603 aa) via site-directed muta-
genesis (details in supplemental text). The human and mouse 
Artemis complementary DNA (cDNA) sequences share 73% 
sequence identity and 81% sequence similarity, and the amino 
acid sequence of mouse Artemis at the site of the mutation is 
nearly identical to that of the human protein (Fig. 1 A).
The targeting construct was comprised of a 2.5-kbp 5 ho-
mology arm that contained the nonsense mutation in exon 14 
and a 2.7-kbp 3 homology arm (Fig. 1 B). The presence of 
the  nucleotide  substitutions  (G1388T/C1390G  within  the 
coding sequence) and integrity of both homology arms were 
confirmed by DNA sequence analysis. Homologously targeted 
recombinants were identified by Southern blotting, and two 
independently derived subclones of successfully targeted em-
bryonic stem (ES) cell lines were injected into C57BL/6 blas-
tocysts. Germline Art+/P70-Neo mice were subsequently bred to 
transgenic mice expressing the Cre recombinase from the EIIA 
promoter  to  delete  the  LoxP-flanked  Neomycin  resistance 
(Neor) gene during early embryogenesis. Progeny harboring 
the Neor-deleted mutant Artemis allele were then intercrossed 
to obtain Art+/+, Art+/P70, and ArtP70/P70 mice (Fig. 1 C). Homo-
zygous Artemis-P70 mice were born in Mendelian numbers 
(Table S1) and survived into adulthood with no obvious de-
velopmental defects.
Expression  of  the  P70  mutant  allele  was  verified  by 
Northern blotting of total RNA isolated from WT, hetero-
zygous, and homozygous Artemis-P70 embryonic fibroblasts 
with a probe that hybridizes near the 3 end of the gene (Fig. 
1 D). In addition, we performed semiquantitative RT-PCR 
analyses of Artemis-P70 expression in spleen and liver using 
gene-specific primers that detect transcripts containing exons 
13–14 (Fig. 1 D). The levels of Artemis messenger RNA 
(mRNA) expressed in the ArtP70/P70 tissues and cells were 
equivalent to controls as measured by both assays. Thus, the 
nonsense mutation did not significantly affect the stability   
of the Artemis mRNA. The RT-PCR products were sub-
cloned and sequenced to verify that the translation stop had 
been introduced into the proper position (D449X) within 
the Artemis coding region (unpublished data).
receptor genes that are generated upon ligation of modified 
coding ends. In contrast, the majority of RS ends are precisely 
joined with no loss or gain of nucleotides; however, the blunt 
ends can also undergo deletions and N insertions (8–12).
Artemis was initially discovered as the gene mutated in hu-
man radiosensitive TB severe combined immunodeficiency 
(RS-SCID), a disorder characterized by a lack of T and B lym-
phocytes and increased cellular radiosensitivity (13, 14). The 
majority of Artemis mutations that cause RS-SCID are located 
within a highly conserved metallo--lactamase/-CASP cata-
lytic domain (residues 1–385 of 692 aa), which distinguishes this 
family of proteins (14). These mutations include genomic exon 
deletions, nucleotide deletions, and nonsense mutations and are 
presumed  to  inactivate  protein  function.  Inherited  hypo-
morphic Artemis alleles have also been identified in patients and 
cause combined immunodeficiency syndromes of varying se-
verity, including Omenn syndrome (14–17). Intriguingly, pre-
mature translation termination mutations that result in loss of 
coding sequence within the nonconserved C terminus (aa 386–
692) can lead to either RS-SCID (17, 18) or partial immuno-
deficiency, in which patients have low but detectable B and T 
lymphocyte populations (15). In this regard, patients harboring 
a truncating Artemis mutation (D451fsX10, referred to as P70 
herein) are characterized by a syndrome of partial immuno-
deficiency and aggressive EBV-associated lymphoma (15).
The predicted protein encoded by the Artemis-P70 allele 
retains the metallo--lactamase/-CASP catalytic core of 
Artemis yet lacks the majority of the nonconserved C termi-
nus (15). The C-terminal domain interacts with and is pho-
sphorylated by DNA-PKcs (19, 20); however, although 
Artemis and DNA-PKcs form a stable complex in cells, the 
functional importance of complex formation or Artemis 
phosphorylation in vivo is not well understood. In this re-
gard, although first proposed to be required for regulation of 
intrinsic nuclease activities (7), biochemical studies of mutant 
Artemis proteins have provided evidence that phosphoryla-
tion by DNA-PKcs is not necessary for activation of endo-
nucleolytic activities (21). In addition, in vitro cellular assays 
examining the V(D)J recombination and DNA repair activ-
ities of exogenously expressed C-terminally truncated Arte-
mis proteins that lack DNA-PKcs phosphorylation sites, 
or mutant forms that cannot bind DNA-PKcs, have led to   
differing results regarding the functional importance of this 
domain (17, 20, 22, 23). Thus, the in vivo relevance of DNA- 
PKcs interaction with and/or phosphorylation of the Artemis 
C terminus remains an open question.
To gain better understanding of the in vivo consequences 
of the Artemis-P70 hypomorphic allele and to elucidate the 
functional importance of the C-terminal domain, we gener-
ated a mutant mouse strain that models this mutation in the 
germline via gene targeting. We find that Artemis-P70 ho-
mozygous mice exhibit impairment but not a complete block 
in T and B lymphocyte development, thereby recapitulating 
the partial immunodeficiency phenotype observed in the pa-
tients. We further characterize the impact of this mutation   
on  DNA  end  processing  and  V(D)J  recombination  using JEM VOL. 206, April 13, 2009 
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Figure 1.  Generation of Artemis-P70 knock-in mice. (A) Hypomorphic Artemis-P70 mutation. Diagram of Artemis cDNA depicting highly conserved 
metallo--lactamase/-CASP domain (boxes) and nonconserved C terminus with the approximate positions of DNA-PKcs S/Q phosphorylation sites indi-
cated (asterisks). An alignment between the Homo sapiens and Mus musculus amino acid sequences adjacent to the nonsense mutation introduced into 
the mouse genomic locus is shown. Lines, identical residues; dotted line, conserved residue; arrows, RT-PCR primers. (B) Targeting strategy for the Arte-
mis-P70 knock-in mutation. The endogenous Artemis locus, targeting construct, knock-in allele, and Neo-deleted knock-in allele are depicted. Bars, 5 and 
3 probes used to screen ES cell clones; stars, Art-P70 mutation. (C) Southern blot analysis of targeted locus. Southern blot analysis of EcoRV-digested 
genomic DNA from Art+/+, Art+/P70, and ArtP70/P70 kidneys from Neo-deleted mice, hybridized with the 5 and 3 probes. Positions of the germline (GL) and 
targeted (P70) alleles are indicated. (D) Northern blot and RT-PCR analyses of Artemis-P70 mRNA. 20 µg of total RNA isolated from Art+/+, Art+/P70, ArtP70/P70, 
and Art/ MEFs was analyzed by Northern blotting using a probe that hybridizes to the 3 end of the mouse Artemis mRNA. -Actin was used as a  
normalization control. RT-PCR was performed on threefold serial dilutions of total RNA from spleen and liver using primers designed to detect transcripts 
encoding exons 13–14 and a normalization control (tubulin). Each experiment was repeated at least three times with RNA isolated from two independent 
cell lines and tissues from two mice of each genotype. Representative results are shown. Black lines indicate that intervening lanes have been spliced out.
Partial combined immunodeficiency caused  
by the hypomorphic Artemis-P70 mutation
Patients harboring the hypomorphic Artemis-P70 allele exhib-
ited lymphocytopenia and died of either recurrent infections or 
lymphoma  progression  (15).  However,  in  contrast  with  the 
TBSCID syndrome caused by null mutations in Artemis, low 
levels of T and B lymphocytes were detected. We examined 
homozygous Artemis-P70 mice to determine whether the 
mouse model recapitulated the partial immunodeficiency ob-
served in patients. We observed that the number of thymocytes 896 IN VIVO FUNCTIONAL ROLES FOR THE ARTEMIS C TERMINUS | Huang et al.
impairment in B cell development resulted in significantly lower 
numbers of surface IgM-expressing cells in ArtP70/P70 bone mar-
row as well as peripheral lymphoid organs (Fig. 2 B and Table I). 
In contrast, B cell development was completely blocked at   
the pro–B stage, and IgM-positive cells were not detected in   
the bone marrow or periphery in Artemis-null mice (Fig. 2 B  
and Table I) (24). No measurable lymphocyte development 
phenotypes were detected in Artemis-P70 heterozygous mice 
compared with controls. Thus, the immune system phenotypes 
observed in the Artemis-P70 mutant mice closely parallel the 
partial immunodeficiency syndrome observed in human patients 
and are distinct from Artemis nullizygosity.
Defective V(D)J rearrangements in Artemis-P70  
homozygous mice
We next examined the impact of the P70 mutation on levels of 
D to J and V to DJ rearrangements within the IgH and TCR- 
loci. To this end, we performed semiquantitative PCR amplifi-
cation of the rearranging loci followed by Southern blotting in 
progenitor lymphocyte populations. Within the TCR- locus, 
we observed a significant retention of the PCR product corre-
sponding to unrearranged alleles in sorted DN thymocytes iso-
lated  from  Artemis-P70  homozygous  mice  compared  with 
controls (Fig. 3 A, GL). We also observed decreased, but readily 
detectable, levels of PCR products representing D1 to J1 
and D2 to J2 rearrangements in ArtP70/P70 DN thymocytes 
(Fig. 3 A). The levels of V to DJ1 rearrangements using 
V10- and V12-specific PCR primers were significantly   
reduced in the homozygous mutant thymocytes compared   
with controls (Fig. 3 A). Together, these results indicate that the   
Artemis-P70 hypomorphic mutation decreases the frequency   
of both D to J and V to DJ rearrangements within the TCR- 
locus, yet substantial levels of recombination do occur.
We also analyzed DH to JH rearrangements in sorted pro- 
and pre–B cells from ArtP70/P70 and control mice using the 
same PCR amplification approach. We used primers 5 of 
DHQ52, the D segment located most proximal to JH1, or a 
degenerate DH primer that amplifies most DH to JH rearrange-
ments, paired with a primer 3 of JH4. We observed a modest 
but reproducible decrease in levels of most DH to JH rear-
rangements in Artemis-P70 pro- and pre–B cells (Fig. 3 C); 
however, significant levels of DH-JH rearrangements were   
in ArtP70/P70 mice was drastically reduced compared with WT 
and heterozygous littermates (10–15% of controls; Table I). In 
addition, significantly lower numbers of splenocytes were ob-
served in the Artemis-P70 mutant mice, reflecting a decrease in 
numbers of mature lymphocytes. Importantly, the impact of the 
hypomorphic Artemis mutation was less severe compared with 
the inactivating mutation. In this regard, the numbers of thymo-
cytes and splenocytes in ArtP70/P70 mice were notably higher in 
comparison with Artemis-null mice (Table I).
We next performed flow cytometric analyses of cell sur-
face markers present on the lymphocytes to determine the ef-
fect of the Artemis-P70 mutation on lymphocyte development. 
Within the TCR- locus, D to J rearrangements are initi-
ated as CD4CD8 (double negative [DN]) thymocytes transi-
tion from the CD44+CD25+ DN2 to the CD44CD25+ DN3 
stage of development. V to DJ rearrangements are completed 
within the DN3 stage of development, and productive TCR-  
rearrangement induces cellular proliferation and differentia-
tion to the CD44CD25 DN4 stage. The ArtP70/P70 mutant 
mice exhibited an impairment in T cell development at the 
DN3 stage, as indicated by an accumulation of progenitors at 
this stage (Fig. 2 A), which is consistent with a defect in success-
ful completion of TCR- rearrangement. Despite this defect, 
a substantial number of mutant developing T cells did progress 
to the CD4+CD8+ (double positive [DP]) stage in the thymus 
and CD4+ or CD8+ single-positive stages in the periphery (i.e., 
lymph nodes and spleen; Fig. 2 A and Table I). In compari-
son, a more severe block in T cell development was caused by 
the Artemis-null mutation as a significantly smaller population   
of thymocytes progressed to the DP stage in a subset of mice 
(Fig. 2 A and Table I) (24).
Flow cytometric analysis of B lymphocyte development 
in ArtP70/P70 mice revealed a similar impairment at the pro-
genitor stages when V(D)J rearrangements occur. Within the 
Ig heavy chain (IgH) locus, DH to JH rearrangements are initi-
ated at the B220+CD43+ pro–B stage, and upon successful 
VH to DJH rearrangement, cells progress to the B220+CD43 
pre–B cell stage. The homozygous Artemis-P70 mice exhib-
ited a defect in the ability of progenitors to transition from 
the pro–B to pre–B stage of development and, thus, we ob-
served a substantial decrease in the percentage and number of 
pre–B cells compared with controls (Fig. 2 B and Table I). This 
Table I.  Impact of the Artemis-P70 mutation on lymphocyte development
Genotype Thymocytes CD4+CD8+ 
thymocytes
Splenocytes CD4+ LN T 
cells
CD8+ LN T 
cells
IgM+ 
splenocytes
Pro–B cells Pro–B cells Pre–B cells Pre–B cells
×106 % ×106 ×106 ×106 % % ×105 % ×105
Art+/+  
(n = 7)
167 ± 102 75 ± 5 70.1 ± 27.95 3.57 ± 2.06 1.72 ± 0.91 19.84 ± 3.82 2.38 ± 0.65 0.71 ± 0.18 15.97 ± 5.69 4.63 ± 1.62
Art+/P70  
(n = 7)
220 ± 106 78 ± 4 94.3 ± 43.2 4.61 ± 2.1 2.1 ± 0.6 18.11 ± 6.2 2.37 ± 0.31 0.897 ± 0.44 10.36 ± 3.25 4.34 ± 4.04
ArtP70/P70  
(n = 6)
19 ± 10 22 ± 15 31.4 ± 19.5 0.43 ± 0.25 0.59 ± 0.2 3.74 ± 1.9 4.44 ± 1.79 1.34 ± 0.56 1.96 ± 0.56 0.75 ± 0.33
Art/  
(n = 6)
3 ± 2 7 ± 10 15.06 ± 11.4 0.059 ± 0.04 0.02 ± 0.013 0.25 ± 0.21 1.5 ± 1.5 0.55 ± 0.74 0.292 ± 0.23 0.1 ± 0.1JEM VOL. 206, April 13, 2009 
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nuclease possesses the necessary activities required to support 
in vivo V(D)J recombination, but it is less efficient compared 
with the WT protein.
DNA end processing during endogenous  
V(D)J rearrangements in Artemis-P70 mice
To gain a more mechanistic understanding of the V(D)J re-
combination defects caused by the Artemis-P70 hypomorphic 
detected. VH to DJH rearrangements involving two frequently 
used VH families, VHQ52 and VH7183, were substantially re-
duced, but not abrogated, in ArtP70/P70 developing B cells 
(Fig. 3 C). These results indicate that the partial B and T   
immunodeficiency caused by Artemis-P70 is the result of an 
impairment, but not complete block, in endogenous V(D)J 
recombination. Thus, despite loss of approximately one third 
of the C-terminal region of the protein, the mutant Artemis 
Figure 2.  Homozygous Artemis-P70 mice exhibit partial immunodeficiency. Flow cytometric analyses were performed on Art+/+, Art+/P70, ArtP70/P70, 
and Art/ mice, as indicated, at 4–5 wk of age. (A) Analysis of T cell development. Thymocytes and lymph node cells were stained with antibodies against 
the indicated cell surface markers. DN thymocytes were gated for the CD25/CD44 analyses. (B) Analysis of B cell development. Bone marrow and spleno-
cytes were stained with antibodies against the indicated cell surface markers. IgM-negative bone marrow cells (IgM) were gated for B220/CD43 analyses. 
Five to six mice of each genotype were analyzed. Representative FACS plots are shown.898 IN VIVO FUNCTIONAL ROLES FOR THE ARTEMIS C TERMINUS | Huang et al.
largest deletion observed was 12 nt, and none of the P nucle-
otide additions was longer than 2 bases (Fig. S1).
The majority of coding joints recovered from ArtP70/P70 
mice  exhibited  characteristics  of  WT  junctions  (Fig.  S1). 
Most nucleotide deletions at Artemis-P70 coding flanks were 
<12 nt, and the majority of the P nucleotide additions were 
1 or 2 nt long (Fig. S1). We did observe a small proportion 
of ArtP70/P70 coding joints with features found in Artemis-
  null junctions, including larger deletions (4 of 51 unique 
sequences with deletions ranging from 13 to 391 bases) and   
mutation, we analyzed the junctional sequences of unselected 
endogenous D to J rearrangements. Rearrangements within 
the IgH and TCR- loci were PCR amplified, subcloned, 
and sequenced. The D-JH and D-J1 coding joints from   
Artemis-null lymphocytes exhibited large deletions, with 
>400 nt deleted from some coding flanks (Fig. S1) (24). In ad-
dition, several unusually long P-nucleotide additions in D-JH 
and D-J1 junctional sequences were observed (up to 6 nt). 
Deletions and P nucleotides within D-JH and D-J1 coding 
joints were also found in WT lymphocytes; however, the 
Figure 3.  Lymphocyte development defects are caused by impaired V(D)J rearrangements. (A) TCR- rearrangements. Genomic DNA from puri-
fied DN thymocytes from Art+/+ and ArtP70/P70 mice and a nonrearranging tissue (tail) was PCR amplified to detect the indicated D to J and V to DJ 
rearrangements. (B) Endogenous TCR- signal joints. Levels of extrachromosomal signal joints formed between TCR-D2 and -J1 RSSs were detected by 
PCR amplification of genomic thymocyte DNA isolated from Art+/+, ArtP70/P70, Art/, and RAG2/ mice. Control PCR amplification of a nonrearranging 
locus was performed to normalize levels of input DNA. D2-J1 signal joints were detected by Southern blot hybridization using an oligonucleotide 
probe. (C) IgH rearrangements. Genomic DNA from sorted pro- and pre–B cell populations from Art+/+ and ArtP70/P70 mice and a nonrearranging tissue 
(tail) was PCR amplified to detect DHQ52 to JH and other DH to JH rearrangements using a degenerate DH primer, as well as VH to DJH rearrangements, as 
indicated. Experiments in A–C were repeated three times with genomic DNA samples from two different sets of mice. Representative results are shown.JEM VOL. 206, April 13, 2009 
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We next subcloned the PCR products, and individual 
clones were digested with ApaLI to determine the proportion 
of precise and imprecise joints. The majority of D2-J1 RS 
junctions from WT thymocytes were precisely joined (80%, 
corrected for redundancy; Table S2), and a comparable propor-
tion (70%) of Art/ RS joints were sensitive to ApaLI diges-
tion. We found that a significantly lower percentage of ArtP70/P70 
RS joints (64%; P = 0.03, Fisher’s exact two-tailed test) were 
precise in comparison with WT junctions (Table S2). Sequence 
analysis of the imperfect RS joints from WT, Art/, and 
ArtP70/P70 mice revealed that nearly all of the junctions ana-
lyzed contained N nucleotide additions (Fig. S2). We also ob-
served deletions from D2 or J1 RS ends in a small subset of 
RS joints analyzed from WT (1 of 15 unique imprecise junc-
tions) as well as Art/ (2 of 18) and ArtP70/P70 (2 of 28) thy-
mocytes. Together, these results indicate that the Artemis-P70 
mutation has a modest impact on the level of fidelity of D2-
J1 RS joining. As the frequency of deleted ends was similar 
in all genotypes examined, our findings suggest that the de-
creased levels of precise RS joining in ArtP70/P70 mice is the 
result of an increase in N nucleotide–modified ends.
The observed nucleotide loss within two Artemis-null D2-
J1 RS joints differs from a previous study that found an absence 
of deletions from D1-D2 and V-D2 RS junctions in Ar-
temis deficiency (11). These incongruent results may be caused 
by distinct mechanisms of end processing at the different recom-
bining V, D, and J segments. In this regard, the extent of N nu-
cleotide addition and deletion of RS ends varies according to the 
sequences of flanking coding segments and the particular loci 
undergoing rearrangement (8–12). Thus, involvement of Arte-
mis nuclease activities in RS end modification may differ de-
pending on the specific rearranging gene segments. Nonetheless, 
these findings support the notion that Artemis is not only re-
quired for processing hairpin coding ends during V(D)J recom-
bination but also participates in modification of blunt RS ends. 
Furthermore, our results indicate that the C-terminal portion of 
the nuclease that is absent in the Artemis-P70 protein plays an 
important role during these activities.
Analysis of V(D)J recombination intermediates  
in Artemis-P70 mutant lymphocytes
In WT developing lymphocytes, RAG1/2-generated hairpin 
coding ends are rapidly processed and joined and, thus, do not 
accumulate to detectable levels (33, 34). In contrast, blunt RS 
ends persist within the context of a stable postcleavage com-
plex before being ligated (33, 35). Covalently closed coding 
ends accumulate in Artemis-null lymphocytes as a result of the 
inability to endonucleolytically cleave the hairpins (24). To as-
sess the impact of Artemis-P70 on end processing, we exam-
ined the levels and structures of hairpin coding and RS ends in 
developing lymphocytes. Genomic DNA isolated from Art+/+, 
ArtP70/P70, and Art/ thymocytes was treated with mung bean 
nuclease (MBN) and/or T4 DNA polymerase. MBN nicks 
hairpins and can endonucleolytically cleave overhanging se-
quences, and T4 DNA polymerase can act upon 3 or 5 over-
hanging ends via its intrinsic exonuclease and polymerase 
P nucleotide additions between 3 and 6 bases (6 of 23 coding 
flanks with P nucleotides). N nucleotide additions were ob-
served in ArtP70/P70 and Art/ coding joints at a comparable 
frequency to that in WT joints. However, we noted that both 
Artemis mutations led to a higher proportion of D-JH and   
D-J1 junctional sequences containing N nucleotide additions 
of >5 bases. We observed that of the WT coding joints with 
N insertions, 6% contained 6 or more nontemplated bases, a 
proportion which is similar to that in previous reports (24–27). 
In comparison, 21% of ArtP70/P70 (P = 0.03, Fisher’s exact 
two-tailed test) and 24% of Art/ (P = 0.02) junctions with 
N nucleotides contained insertions of >5 bases (Fig. S1) (this 
study and reference 24).
In patients harboring the P70 mutation, the junctional   
sequences of eight expressed TCR- cDNAs exhibited an 
absence of N nucleotides (15). The precise molecular bases 
for the differing observations in our mouse model are unclear; 
however, one potential influencing factor is that the human 
subjects experienced multiple recurrent infections. Thus, ab-
errant immune responses in the context of lymphopenia may 
have had an impact on the selected TCR repertoire of the 
low-level mature peripheral T cells observed in the patients 
(28–30). In our analyses, we have examined junctional se-
quences of >70 unique D to J rearrangements in immature 
lymphocyte populations from Artemis mutant mice housed 
in a specific pathogen-free environment; thus, the mouse se-
quences may allow for a more unbiased analysis of junctional 
diversity. In this regard, a recent study reported the sequences 
of DH-JH coding joints recovered from immature B cells iso-
lated from bone marrow mononuclear cultures of Artemis 
mutant patients, including one patient harboring a distinct 
premature translation termination mutation (17). The major-
ity of DH-JH junctional sequences analyzed contained N nu-
cleotides, and one third of the coding joints with N additions 
contained insertions of >5 bases.
We also examined the levels and fidelity of RS end joining 
in the Artemis-P70 homozygous mice. RS joints formed upon 
precise ligation of heptamers can generate the recognition se-
quence for ApaLI by virtue of the conserved CAC triplet 
flanking the majority of RAG1/2 cleavage sites (31, 32). A 
proportion of blunt RS ends undergoes modification in WT 
lymphocytes and, thus, is resistant to digestion by ApaLI be-
cause of N nucleotide additions and/or deletions (8–12). Arte-
mis does not play a direct role in RS end joining; however, it 
has been implicated in processing the blunt ends before ligation 
(11). In this regard, levels of RS joint formation are unaffected 
in Art/ mice; however, the proportion of ApaLI-resistant 
junctions at certain loci have been found to be decreased, in 
part as the result of an absence of nucleotide deletions (11). We 
assessed the impact of the Artemis-P70 mutation on RS end 
processing and joining within the TCR- locus using a PCR 
strategy. We amplified the joints formed between the D2 and 
J1 RSSs and observed that the levels were similar in ArtP70/P70 
thymocytes compared with Art+/+ and Art/ thymocytes 
(Fig. 3 B). These results indicate that Artemis-P70 does not 
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with RAG1 and RAG2 expression constructs and a coding join-
ing plasmid substrate (pJH290). Levels of V(D)J recombination 
were quantitated by transformation of recovered plasmids into 
Escherichia coli and selection of successfully recombined products 
via ampicillin and chloramphenicol resistance. We observed that 
all mutant forms of Artemis complemented the severe coding 
joining defect (Table II).
We analyzed the junctional sequences of recombined plas-
mids to identify qualitative differences in coding end processing 
and found that coding joint sequences recovered from Art/ 
cells expressing the mutant Artemis constructs were similar to 
those from WT ES cells or mutant cells complemented with 
WT Artemis (Fig. S3). Overall, the coding joint sequences ex-
hibited similar numbers of P and N nucleotide additions and de-
letions. The rare recombinants isolated from Artemis-null cells 
exhibited the hallmark large deletions and longer than average   
P nucleotide additions. These results demonstrate that the hypo-
morphic Artemis mutations that lead to partial immunodefi-
ciency in patients, D451X and T432X, retain the necessary 
activities, thereby rendering them blunt. Thus, enzymatic 
treatment of DNA ends with either or both enzymes followed 
by ligation-mediated PCR (LM-PCR) can reveal distinct 
structures of coding ends.
We ligated linkers to untreated genomic thymocyte DNA 
or DNA treated with T4 DNA polymerase and then PCR 
amplified products corresponding to 3 D1 RS ends within 
the rearranging TCR- locus. The LM-PCR products were 
detected via Southern blot analyses using an oligonucleotide 
probe. We readily detected RS ends in untreated genomic 
DNA isolated from ArtP70/P70 thymocytes (Fig. 4 A). To as-
sess the presence of modified nonblunt RS ends, we treated 
the DNA with T4 polymerase before the linker ligation. We 
did not observe a significant increase in band intensity or the 
appearance of additional bands (Fig. 4 A); thus, the majority 
of D1 3 RS ends in ArtP70/P70 thymocytes are blunt, as ob-
served in WT and Art/ mice. Modified RS ends are likely 
to be present in developing thymocytes, as indicated by the 
presence of imprecise RS joints containing N nucleotides 
and deletions; however, accurate assessment of the levels is 
beyond the sensitivity of the LM-PCR assay (35, 36).
We next assessed the impact of the Artemis-P70 mutation 
on levels of D1 3 coding ends in DNA samples treated 
with MBN and/or T4 polymerase. We detected substantial 
levels of LM-PCR products corresponding to hairpin coding 
ends in ArtP70/P70 thymocytes; however, the levels were con-
sistently three- to fivefold lower than those observed in Arte-
mis-null cells (Fig. 4 B). Similar results were observed at J1 
5 coding ends (unpublished data). Hairpin coding ends were 
not detected in WT thymocytes, as has been previously es-
tablished (33, 34). Treatment of the thymocyte DNA samples 
with T4 DNA polymerase did not impact the levels of LM-
PCR products in any of the genotypes (Fig. 4 B); thus, open 
hairpins with 5 or 3 overhanging ends do not persist in 
ArtP70/P70 thymocytes. These findings support the notion that 
the Artemis-P70 mutant protein is defective for hairpin cod-
ing end opening; however, it does possess moderate in vivo 
endonucleolytic activity, as indicated by reduced accumula-
tion of coding ends compared with Artemis nullizygosity.
Coding joining defects in Artemis-P70 mutant cells
To gain additional mechanistic insights into the V(D)J recombi-
nation defects caused by the Artemis-P70 mutation, we used a 
plasmid-based assay in cultured cells (37). Initially, we analyzed 
the ability of mutated human Artemis cDNA expression con-
structs to complement the V(D)J recombination defects in Arte-
mis-null  ES  cells  (38).  We  generated  three  C-terminal 
truncations, including D451X, which models the human P70 
mutation, T432X, and S385X via site-directed mutagenesis. 
The T432X protein mimics a distinct human Artemis hypo-
morphic frameshift mutation that is associated with partial im-
munodeficiency (15). The S385X C-terminally truncated 
protein is comprised of the highly conserved metallo--lac-
tamase/-CASP domain that lacks the entire nonconserved C 
terminus and represents the catalytic core (23). The mutant or 
WT Artemis constructs were cotransfected into Art/ ES cells 
Figure 4.  V(D)J recombination intermediates in Artemis-P70 thy-
mocytes. (A) Levels of RS ends in Artemis-P70 DN thymocytes. Genomic 
DNA from sorted DN thymocytes from Art+/+, ArtP70/P70, and Art/ mice 
was either untreated or treated with T4 DNA polymerase. Linkers were 
ligated to the blunt ends, followed by PCR amplification of TCR-D1 3 
RS ends (179 bp). The LM-PCR products were detected by Southern blot 
hybridization using locus-specific oligonucleotide probes. (B) Accumula-
tion of coding hairpin ends in Artemis-P70 DN thymocytes. The genomic 
DNA from sorted DN thymocytes was untreated or treated with MBN and/or 
T4 DNA polymerase, as indicated, and then the LM-PCR reactions were 
performed to detect 3 TCR-D1 coding ends (125 bp), as described in A. 
Control PCR amplification of a nonrearranging locus was performed to 
normalize levels of input DNA. Experiments in A and B were repeated a 
minimum of three times with genomic DNA isolated from at least two 
different mice of each genotype. Representative results are shown.JEM VOL. 206, April 13, 2009 
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distinct and most exhibited large deletions from both coding 
flanks (Fig. S4). Together, these findings support the notion that 
the Artemis C terminus is not required for intrinsic catalytic ac-
tivities and indicate that this region of the nuclease facilitates ef-
ficient coding end processing and joining.
Hypomorphic Artemis mutation results in intermediate 
hypersensitivity to DSBs and genome instability
One hallmark feature of cell lines derived from human RS-
SCID patients harboring null mutations in Artemis is increased 
sensitivity to DNA DSB-inducing agents, such as ionizing radia-
tion (IR), and the radiomimetic chemotherapeutic agent bleo-
mycin, and Artemis-null mouse cells recapitulate this phenotype 
(13, 24, 38). To determine the impact of the Artemis-P70 muta-
tion on general DNA DSB repair, we examined the relative 
sensitivities of Art+/+, ArtP70/P70, and Art/ primary MEFs. We 
found that the ArtP70/P70 MEFs exhibited an intermediate hyper-
sensitivity to IR compared with Artemis nullizygosity, which is 
consistent with a partial loss of DNA repair functions (Fig. 5 A). 
We also consistently observed that Artemis-P70 homozygosity 
resulted in intermediate survival upon exposure to bleomycin, 
although the impact was less pronounced compared with IR 
hypersensitivity (Fig. 5 B).
We next assessed the impact of the Artemis-P70 mutation 
on chromosomal stability in early passage primary MEFs. Arte-
mis-null cells accumulate increased levels of chromosomal aber-
rations  (24,  38),  which  likely  result  from  the  presence  of 
unrepaired DNA ends. We found that ArtP70/P70 cells harbored 
increased levels of chromosomal aberrations at 24 h after 200 rads 
IR, particularly chromosome and chromatid breaks, com-
pared with the WT cells (Table IV). The level of aberrations 
in Art-P70 MEFs was similar to that observed in Artemis-
null cells; thus, the P70 hypomorphic Artemis mutation leads 
to significantly increased genome instability. These results 
catalytic activities to properly process the hairpin coding ends 
during V(D)J recombination when overexpressed. These find-
ings are in agreement with previous studies, which reported that 
the DNA-PKcs interaction domain of Artemis was largely dis-
pensable for V(D)J recombination in cells using model substrates 
(17, 20, 22, 23). However, these in vitro results did not recapitu-
late our in vivo observations of impaired V(D)J rearrangements 
and hairpin coding end accumulation within the endogenous 
antigen receptor loci in ArtP70/P70 lymphocytes.
To more accurately assess the impact of the Artemis-P70 
mutation on V(D)J recombination, we compared frequencies 
of coding joint formation in Art+/+, Art+/P70, ArtP70/P70, and 
Art/  primary  transformed  mouse  embryonic  fibroblasts 
(MEFs). We observed a dramatic decrease in recombination 
frequency in Artemis-P70 homozygous cells, which was of a 
similar  magnitude  to  that  observed  in  Artemis-null  MEFs   
(Table III). Coding joining in ArtP70/P70 cells was restored 
nearly to WT levels by expression of the full-length Artemis 
protein. These results in cells expressing endogenous levels of 
the Artemis-P70 protein are in sharp contrast to the comple-
mentation assay described in the previous section and empha-
size the potential limitations of heterologous overexpression of 
mutant proteins in characterizing physiological activity. Con-
flicting reports concerning the V(D)J recombination activities 
of mutant Artemis proteins are likely influenced by variable 
levels of exogenous expression (17, 20, 22, 23).
Qualitative analyses of the coding joints recovered from the 
ArtP70/P70 MEFs revealed that, despite the severe decrease in re-
combination frequency, the sequences of the coding joints were 
similar to those observed in WT MEFs (Fig. S4). The majority 
of Artemis-P70 junctions were characterized by P and N nucle-
otide additions of normal length and small nucleotide deletions, 
with the exception of two junctions exhibiting larger deletions 
(>12 bases). The joints from Artemis-null MEFs were clearly 
Table II.  C-terminally truncated Artemis proteins complement Artemis-null V(D)J coding joining defect
Cell lines AmpR/AmpR + ChlR Recombination frequency Relative levels
%
Experiment 1
  TC1 330/24,000 1.3 1.0
  Art/ 35/20,100 0.17 0.13
  Art/ + hArt 3,410/250,000 1.4 1.08
  Art/ + D451X 840/42,500 2 1.54
  Art/ + T432X 5,500/405,000 1.3 1.0
  Art/ + S385X 460/42,000 1.09 0.84
  TC1 (no RAG) 0/2,600 <0.038 <0.029
Experiment 2
  TC1 1,753/285,066 0.615 1.0
  Art/ 278/99,467 0.279 0.45
  Art/ + hArt 5,370/194,867 2.76 4.5
  Art/ + D451X 2,045/82,133 2.49 4.1
  Art/ + T432X 3,819/178,000 2.15 3.5
  Art/ + S385X 1,444/103,133 1.40 2.3
  TC1 (no RAG) 73/50,800 0.144 0.2902 IN VIVO FUNCTIONAL ROLES FOR THE ARTEMIS C TERMINUS | Huang et al.
T432X, and S385X proteins from 293T cells and then incu-
bated them with DNA-PKcs in the presence of -[32P]ATP and 
duplex DNA. We observed a substantial reduction in levels of 
phosphorylation of D451X, T432X, and S385X compared with 
WT Artemis, whereas the C terminus alone is efficiently phos-
phorylated (Fig. 6 B). These results indicate that the protein en-
coded by the mutant Artemis P70 allele, D451X, is capable of 
interacting with DNA-PKcs; however, it does not undergo 
phosphorylation.
Impact of Artemis mutations on intrinsic nuclease activities
We next analyzed the nuclease activities intrinsic to Artemis-
D451X and regulation by DNA-PKcs. Initially, we examined 
the activity of full-length D451X and S385X proteins on a   
32P 5 end-labeled single-strand oligonucleotide substrate and 
observed that the truncated enzymes retained robust 5 to 3 
exonuclease activity, as indicated by release of the single labeled 
nucleotide (Fig. 6 C). We next assayed hairpin opening activ-
ity in the presence or absence of DNA-PKcs. In the presence 
of DNA-PKcs, the full-length protein was activated to cleave 
the 32P 5 end-labeled 20-bp hairpin substrate to yield major 
products of 22 and 23 bases at positions 2 and 3 nt 3 of the 
apex (Fig. 6 D, left) (7). We observed that the D451X protein 
exhibited significant, although reduced, DNA-PKcs–depen-
dent hairpin opening activity, yielding products of the same 
length as WT Artemis (Fig. 6 D). We also examined the levels 
of DNA-PKcs–dependent and –independent cleavage activity 
on a 15-nt 3 overhang substrate comprised of a 32P 5 end-
  labeled 36-mer annealed to a 21-mer. The D451X protein   
exhibited endonucleolytic activity that was dependent on 
DNA-PKcs and primarily cleaved the substrate at positions 4 
support the notion that the hypomorphic P70 allele results in 
partial loss of Artemis function, not only for end processing 
during the lymphoid-specific V(D)J recombination but also 
general DSB repair.
Interaction and phosphorylation of mutant Artemis proteins 
with DNA-PKcs
To elucidate the molecular defects caused by the Artemis-P70 
mutation, we examined the consequences of this mutation on 
interactions with DNA-PKcs. Using a coimmunoprecipitation 
assay, we directly examined the ability of the Artemis-D451X 
(P70)  and  the  T432X  and  S385X  proteins  to  interact  with 
DNA-PKcs. Histidine and myc-tagged WT and mutant Arte-
mis proteins were expressed in 293T cells and then immunopre-
cipitated using an anti-myc antibody. The coimmunoprecipitated 
proteins were analyzed by Western blotting using anti-histidine 
and anti–DNA-PKcs monoclonal antibodies. We observed that 
the D451X and T432X proteins stably interacted with DNA-
PKcs to a similar extent as full-length Artemis; however, the 
S385X C-terminally truncated protein did not (Fig. 6 A). We 
also expressed the regions of Artemis deleted in D451X and 
S385X proteins and found that the C terminus (aa 386–692) re-
tains the ability to coimmunoprecipitate DNA-PKcs (Fig. 6 A); 
however, a polypeptide comprised of residues 452–692 does not 
(unpublished data). These results are consistent with previous 
studies that identified the nonconserved Artemis C terminus as 
important for stable DNA-PKcs binding (20, 22).
We examined the ability of the mutant Artemis proteins to 
be phosphorylated by DNA-PKcs, as the majority of phosphor-
ylation sites have been mapped to the nonconserved C-terminal 
region (19, 21, 22). To this end, we purified the WT, D451X, 
Table III.  Defective V(D)J coding joining in homozygous Artemis-P70 MEFs
Cell lines AmpR/AmpR + ChlR Recombination frequency Relative levels
%
Experiment 1
  WT (No Rag) 2/9,400 0.02 0.02
  WT 399/36,500 1.09 1.0
  Art+/P70 2,514/84,800 2.96 2.7
  ArtP70/P70 7/51,100 0.01 0.01
  Art/ 17/30,900 0.05 0.05
Experiment 2
  WT (No Rag) 5/23,800 0.02 0.06
  WT 48/9,800 0.49 1.0
  Art+/P70 104/15,400 0.68 1.4
  ArtP70/P70 5/50,800 0.01 0.02
  Art/ 8/50,800 0.02 0.03
Experiment 3
  WT 1,933/602,500 0.32 1.00
  ArtP70/P70 10/51,750 0.02 0.06
  ArtP70/P70 + hArt 66/29,750 0.22 0.69
  Art/ 67/148,000 0.03 0.08
  Art/ + hArt 1,462/282,500 0.52 1.63
  No RAG 0/6,500 <0.02 <0.06JEM VOL. 206, April 13, 2009 
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hairpin  nicking  activity  in  Mn2+  which  is  independent  of 
DNA-PKcs and that this activity is not further stimulated upon 
addition of the kinase (Fig. 6 E, left). In fact, we observed that 
in reaction mixtures containing Mn2+, the levels of hairpin 
cleavage were consistently higher for D451X and S385X than 
for the full-length protein. The WT, D451X, and S385X pro-
teins  also  exhibited  significant  DNA-PKcs  independent  3 
overhang cleavage activity in Mn2+ that was not enhanced by 
the presence of DNA-PKcs (Fig. 6 E, right). We noted that 
Mn2+ led to the appearance of a range of products correspond-
ing to additional cleavage sites within the 3 single-strand flap. 
Thus, the presence of Mn2+ abrogates the requirement for 
DNA-PKcs in activating endonucleolytic activities of Artemis 
and circumvents the need for remodeling of the overhang sub-
strate and/or conformation of protein complexes by the pro-
tein kinase, as has been proposed for DNA-PKcs–dependent 
overhang cleavage in Mg2+ (20). Together, these results dem-
onstrate that the C-terminally truncated proteins possess robust 
endonucleolytic  activity  in  the  absence  of  phosphorylation 
and, in the case of S385X, without stable interaction with 
DNA-PKcs under certain reaction conditions.
DISCUSSION
A mouse model of partial immunodeficiency caused  
by a hypomorphic Artemis mutation
In this study, we examined the molecular mechanisms underly-
ing a syndrome of partial B and T immunodeficiency associated 
with lymphoma in patients harboring a hypomorphic Artemis  
allele, P70. The Artemis-P70 mutation results in loss of coding 
sequence for over one third of the polypeptide, including the 
region of the C terminus that contains the majority of phospho-
rylation sites for DNA-PKcs (19, 21, 22). We demonstrate that 
lymphocyte development in ArtP70/P70 mice is impaired at the 
stages during which TCR and Ig gene rearrangements occur, 
thereby resulting in a marked decrease in numbers of mature B 
and T lymphocytes compared with Art+/P70 and WT controls. 
However, the phenotype is less severe compared with Art/ 
mice. In this regard, ArtP70/P70 mice have substantial populations 
of CD4+CD8+ DP thymocytes and detectable levels of CD4+ or 
CD8+ single-positive peripheral T cells as well as B220+IgM+ 
bone marrow and peripheral B cells. In contrast, Artemis-null 
mice are characterized by a block in B cell development and only 
a subset of mice exhibit “leaky” T cell development (this study 
and reference 24). Thus, the phenotypes of homozygous Arte-
mis-P70 mice are clearly distinct from those observed in Artemis 
nullizygosity and confirm that the mutation represents a partial 
loss-of-function allele.
We found that the lymphocyte development defects ob-
served in ArtP70/P70 mice are a result of reduced efficiency of 
coding end processing during endogenous V(D)J recombina-
tion, as indicated by an accumulation of hairpin ends and lower 
levels of both D to J and V to DJ rearrangements within TCR 
and Ig loci. We observed a similar defect in V(D)J recombina-
tion using a cellular transient transfection V(D)J recombination 
assay in Artemis-P70 homozygous mutant MEFs. Therefore, al-
though previous in vitro cellular transfection studies examining 
and 5 bases 3 of the double-to-single strand transition, as ob-
served for WT Artemis (Fig. 6 D, left). Thus, Artemis-D451X 
possesses DNA-PKcs–dependent endonucleolytic activities on 
hairpin and 3 overhang structures; however, we consistently 
observed lower levels of cleavage products compared with the 
WT enzyme. The S385X protein exhibited DNA-PKcs–inde-
pendent endonucleolytic activity on the hairpin and 3 over-
hang substrates that was slightly stimulated upon addition of 
the protein kinase, which is consistent with previous analyses 
of a similar truncated form of Artemis (aa 1–382) (20). To fur-
ther evaluate the endonuclease activities intrinsic to the mutant 
Artemis proteins, we assayed hairpin and 3 overhang cleavage 
in the presence of manganese (Mn2+), rather than magnesium 
(Mg2+), as the divalent metal cofactor. We found that WT Ar-
temis, as well as the D451X and S385X proteins, possesses 
Figure 5.  Defective DNA repair and increased genomic instability 
caused by the Artemis-P70 mutation. (A) IR sensitivity. Art+/+, ArtP70/P70, 
and Art/ primary MEFs were exposed to the indicated amounts of IR 
and then plated in duplicate. The cells were harvested 7 d after IR, stained 
with trypan blue, and then counted. The percentage of survival compared 
with untreated cultures is plotted as a function of IR dose. (B) Bleomycin 
sensitivity. Primary MEFs were plated and then treated with the indicated 
amounts of bleomycin at 24 h. Cellular survival was determined as de-
scribed in A. The curves represent the mean of three independent experi-
ments using two independent cell lines of each genotype. Error bars 
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modeled after the P70 mutant allele, retains robust 5 to 3 single-
strand exonuclease activity. The truncated protein interacts stably 
with  DNA-PKcs  and  exhibits  significant,  although  reduced, 
DNA-PKcs–dependent endonucleolytic activity despite the in-
ability to be phosphorylated. These results are consistent with 
previous studies indicating that phosphorylation within the Arte-
mis C terminus is dispensable for activation of endonucleolytic 
activity (21). Our in vitro observations that the V(D)J recombi-
nation defect in Artemis-null cells can be fully complemented by 
exogenous expression of the D451X protein support the notion 
that the C terminus is not essential for Artemis end processing 
activities per se. However, we did observe consistently lower 
levels of endonucleolytic activities intrinsic to the D451X pro-
tein, indicating that the C terminus plays a role in modulating 
Artemis nuclease activities independent of DNA-PKcs interac-
tion. In this regard, the reduced 3 overhang cleavage activity 
observed in vitro may result in the distinct N nucleotide addi-
tions observed within coding and RS joints in vivo.
One additional in vivo impact of C-terminal truncation and 
resultant loss of Artemis phosphorylation may be mislocalization 
or inefficient recruitment of the mutant protein to DNA ends. 
The phosphorylated form of Artemis forms discrete nuclear foci 
in cells (22) and preferentially associates with chromatin in re-
sponse to DNA damage (22, 39), suggesting that phospho-Arte-
mis may have a distinct function within the context of chromatin. 
Although the precise nature of this function is unclear, cofrac-
tionation of phospho-Artemis with DNA-PKcs, XRCC4, and 
Ku in response to DNA damage suggests that localization to 
chromatin facilitates repair of DNA DSBs (39). Likewise, in vitro 
and cellular studies indicate that an autophosphorylated form of 
DNA-PKcs has a higher affinity for the phosphorylated form of 
Artemis (unpublished data and references 19, 20). The truncated 
Artemis-P70 protein lacking the major phosphorylation sites may 
not properly interact with chromatin or other DNA repair fac-
tors. Thus, the hypomorphic mutation would impair the ability 
of Artemis to be stably targeted to DSBs and have an impact on 
its ability to efficiently act upon DNA ends.
Implications of aberrant Artemis nucleolytic activities
As aberrant repair of DNA DSBs can lead to oncogenic chro-
mosomal aberrations and cancer (25, 40–42), our findings 
the functional consequences of Artemis mutations concluded that 
neither the C terminus nor DNA-PKcs–dependent phosphory-
lation is required for V(D)J recombination (19, 21–23), our find-
ings clearly establish that the C-terminal region of the protein is 
indeed required for efficient in vivo V(D)J rearrangements.
Consequences of deletion of the Artemis C terminus  
on DNA end processing
We found that the majority of coding joint sequences from the 
ArtP70/P70 mutant mice and cells exhibit similarity to WT junc-
tions. The Artemis-P70 junctions harbored small deletions and 
P nucleotide additions of normal length, and only a small subset 
of sequences contained the hallmark long P insertions or large 
deletions characteristic of Art/ junctions. These results indi-
cate that the Artemis-P70 mutant protein can be targeted to 
coding ends and nick the hairpins once recruited, although with 
reduced efficiency compared with the WT enzyme. We also 
observed aberrant N nucleotide additions within both coding 
and RS joints in the ArtP70/P70 mice. In this regard, significantly 
higher frequencies of DH-JH and D1-J1 coding joints con-
taining N insertions of longer than 5 bases and imprecise RS 
joints containing N nucleotides were observed. These findings 
suggest that, in addition to hairpin nicking, Artemis may func-
tion to nucleolytically trim TdT-synthesized nontemplated bases 
added to both coding and RS ends and that loss of the Artemis 
C terminus has an impact on these activities. Alternatively, Arte-
mis may modulate TdT interactions with and/or accessibility to 
DNA ends, thereby altering TdT-dependent end processing in 
the mutant lymphocytes.
Our studies revealed that primary homozygous Artemis-P70 
MEFs are hypersensitive to the DNA DSB-inducing agents IR 
and bleomycin but less sensitive than Art/ MEFs. Truncation 
of the Artemis C terminus also results in increased genomic in-
stability, as we observed significantly higher levels of chromo-
somal anomalies in irradiated ArtP70/P70 MEFs. Therefore, the 
impact of the P70 mutation on Artemis function is not restricted 
to end processing during the specialized process of V(D)J recom-
bination but also impacts its roles in general DSB repair and 
maintenance of genome stability.
What are the consequences of C-terminal truncation on   
Artemis activities? We found that the D451X protein, which was 
Table IV.  Increased IR-induced chromosomal anomalies in hypomorphic Artemis-P70 MEFs
Type of anomaly Art+/+ ArtP70/P70 Art/
Chromosome/chromatid breaks 15 73 50
Fusions 7 16 11
Radial structure 0 4 0
Ring structure 6 6 13
Unusual structures 2 13 18
Total anomalies 30 108 92
Chromosomes scored 2,053 2,585 1,541
Metaphases scored 54 58 51
Number of anomalies per chromosome 0.015 0.042 0.060
Number of anomalies per metaphase 0.56 1.86 1.80JEM VOL. 206, April 13, 2009 
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In further support of this hypothesis, two relatives of a patient 
harboring a similar hypomorphic Artemis allele, which leads 
to a frameshift at codon 393 followed by a stop mutation after 
8 codons, were diagnosed with acute lymphoblastic leukemia; 
however, the patient died of pneumonia at 3 mo of age, be-
fore developing overt lymphoid malignancy (18). In future 
studies, it will be of interest to examine the impact of the   
Artemis-P70 mutation on lymphoid neoplasia alone and in   
the context of p53 mutation.
Summary
Together, our current findings provide insights into the mole-
cular  mechanisms  that  underlie  partial  combined  immuno-
deficiency in patients caused by a hypomorphic Artemis allele. 
raise the possibility that the hypomorphic Artemis-P70 allele 
may predispose to tumorigenesis. In support of this notion, 
patients harboring the Artemis-P70 mutation developed ag-
gressive B lymphoma (15). The molecular basis for tumori-
genesis in these patients was not clear, as the lymphomas were 
associated with EBV yet also exhibited characteristics that are 
not generally associated with EBV-driven B cell proliferation, 
including a clonal cellular origin, increased genome instability, 
and clonal chromosomal aberrations (15). Our observations 
that the Artemis-P70 allele results in defective DNA DSB re-
pair and increased genome instability provide evidence that 
this hypomorphic mutation could contribute to tumorigene-
sis,  as  observed  in  mouse  models  harboring  null  alleles  in 
NHEJ genes in the context of p53 mutation (25, 41, 42).   
Figure 6.  Impact of Artemis C-terminal truncations on DNA-PKcs interactions and nuclease activities. (A) Coimmunoprecipitation of Artemis–
DNA-PKcs. Constructs expressing c-myc and 6× histidine-tagged full-length (WT), D451X, T432X, and S385X mutant forms of Artemis, and the C terminus 
alone (C-term), were transfected into 293T cells, immunoprecipitated with –c-myc, and then analyzed by Western blotting probed with -6×His anti-
bodies. The membranes were then reprobed with –DNA-PKcs antibodies. Mock, untransfected 293T cells; (), no immunoprecipitation; (+), immuno-
precipitated. (B) Phosphorylation of Artemis mutants. WT and mutant Artemis proteins (as indicated) purified from 293T cells were incubated with purified 
DNA-PKcs and -[32P]ATP. Phosphorylation products were analyzed by SDS-PAGE followed by autoradiography. Arrowheads, positions of truncated mu-
tant proteins; closed circle, autophosphorylated DNA-PKcs. Black lines indicate that intervening lanes have been spliced out. (C) 5 to 3 single-strand 
exonuclease activity. WT and mutant Artemis proteins (as indicated) were incubated with a 32P 5 end-labeled single-strand oligonucleotide substrate  
(20 nt) for 2 h at 37°C. The reactions were analyzed on a 17% denaturing polyacrylamide gel followed by autoradiography. The positions and structures of 
the input substrate and 1-nt product are indicated on the left. Asterisks, 32P 5 end label. (D) DNA-PKcs–dependent endonuclease activities in the pres-
ence of MgCl2. Endonuclease reactions were performed with a 32P 5 end-labeled 20-bp hairpin substrate (left) or a 3 overhang substrate comprised of a 
[32P] 5 end-labeled 36-mer annealed to a complementary 21-mer (right) in the presence or absence DNA-PKcs and ATP, as indicated. All reactions con-
tained 10 mM MgCl2 and were analyzed as described in A. The positions and structures of the input substrates and products are indicated. Arrows, sites of 
endonucleolytic cleavage; asterisks, 32P 5 end label. (E) DNA-PKcs–independent hairpin opening activity in the presence of MnCl2. Endonuclease reactions 
were performed with the 32P 5 end-labeled hairpin and 3 overhang substrates as described in B, except, the reactions contained 10 mM MnCl2. Reac-
tions were analyzed as described in A. The positions and structures of the input substrates and products are indicated. C, mock transfection; (), input 
substrate. All assays were repeated at least three times with proteins from three or more independent transfections. Asterisks, 32P 5 end label.906 IN VIVO FUNCTIONAL ROLES FOR THE ARTEMIS C TERMINUS | Huang et al.
was repeated a minimum of three times with genomic DNA isolated from at 
least three different mice of each genotype.
Survival and genomic instability assays. Passage 2 (P2) primary MEFs 
of the indicated genotypes were exposed to the indicated doses of  rays 
from a 137Cs source and plated in duplicate at 2 × 105 cells per 6-cm gelati-
nized dish. The cells were cultured for 7 d, trypsinized, and stained with try-
pan blue. Live cells were counted using a hemacytometer. For bleomycin 
sensitivity, P2 MEFs were plated at 1.5 × 105 cells per 6-cm gelatinized dish 
and treated with the indicated doses of drug for 24 h. Cells were cultured for 
4 d after the drug was removed, harvested, and live cells were counted. Per-
centage of survival was calculated as the number of treated cells over un-
treated control cells. Each experiment was repeated a minimum of three 
times with at least two independently derived cell lines.
P2 primary MEFs of the indicated genotypes were exposed to 200 rads of 
 rays from a 137Cs source. After exposure, the cells were plated at 1.5 × 106 
cells per 10-cm gelatinized dish and allowed to recover for 24 h. Cells were 
treated with colcemid for 4 h, harvested, and fixed. Metaphases were analyzed 
by DAPI staining. Data represent the results from two experiments performed 
on two independently derived cell lines.
Transient V(D)J recombination assay. Transient V(D)J recombination assay 
was performed as previously described (details in supplemental text) (37).
In  vitro  phosphorylation  assay. Reaction mixtures contained 25 mM 
Hepes, pH 7.8, 50 mM KCl, 10 mM MgCl2, 2 mM EGTA, 1 mM DTT,   
0.3 mg/ml sheared salmon sperm DNA, 0.14 µM -[32P]ATP, and purified 
WT or mutant Artemis proteins in a 30-µl volume (details in supplemental text). 
Kinase reactions were initiated upon addition of 350 ng of purified DNA-
PKcs and were incubated at 37°C for 90 min. Reactions were stopped upon 
addition of SDS/EDTA and proteins were fractionated on a 10% SDS-PAGE 
gel. The gels were then dried and images were obtained by autoradiography.
DNA nuclease assays. The single-strand DNA nuclease assay was performed 
in reaction mixtures containing 50–100 ng Artemis WT and mutant proteins, 
0.25 pmol 32P 5 end-labeled 20-nt oligo-dA substrate, 50 mM Tris, pH 8.0,   
10 mM MgCl2, 20 mM NaCl, 0.25 mM ATP, 0.05 µg/µl BSA, and 1 mM 
DTT in a 50-µl volume. The mixtures were incubated at 37°C for 2 h, stopped 
with EDTA and formamide, and then loaded onto a 20% denaturing acrylamide 
gel. The hairpin endonuclease assays were performed in reaction mixture con-
taining 25 mM Tris, pH 8.0, 10 mM MgCl2, or 10 mM MnCl2 (where indi-
cated), 0.125 pmol 32P 5 end-labeled hairpin DNA substrate, 0.05 µg/µl BSA, 
0.25 mM ATP, and 0.25 µM of a 32-bp double-stranded DNA oligonucleotide 
in a 20-µl volume. Reactions were incubated at 37°C for 2 h. The 3 overhang 
endonuclease assays were performed as described for hairpin nicking, except that 
0.25 pmol 32P 5 end-labeled 3 overhang substrate was incubated with the puri-
fied Artemis proteins for 1 h. Where indicated, 350 ng DNA-PKcs was added 
to each reaction. Nuclease reactions were stopped with EDTA and formamide 
and then electrophoresed through a 17% denaturing acrylamide gel. Products 
were visualized by autoradiography. Each assay was repeated at least three times 
with two or more independent preparations of the purified Artemis proteins.
Online supplemental material. Supplemental text contains a detailed de-
scription of the materials and methods and primer sequences. Fig. S1 shows 
sequences of endogenous IgH and TCR- coding joints. Fig. S2 shows se-
quences of ApaLI-resistant RS joints. Fig. S3 shows sequences of coding joints 
recovered from transient transfection complementation V(D)J recombination 
assay in ES cells. Fig. S4 shows sequences of coding joints recovered from tran-
sient transfection V(D)J recombination assay in Artemis-P70 MEFs. Table S1 
shows Mendelian inheritance of the Artemis-P70 allele. Table S2 shows fre-
quency of ApaLI-sensitive D2-J1 signal joints. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20082396/DC1.
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We provide evidence that the mutant Artemis-P70 nuclease is 
defective for DNA end processing during endogenous V(D)J 
recombination and exhibits reduced endonucleolytic activities 
despite retaining stable interaction with DNA-PKcs. Loss of the 
C terminus abrogates the ability of the Artemis-P70 protein to 
be phosphorylated by DNA-PKcs. Thus, although dispensable 
for activating endonucleolytic activities, our findings indicate 
that phosphorylation of the Artemis C terminus may play an 
important role in modulating in vivo functions. Importantly, we 
find that the Artemis-P70 mutation not only impairs end pro-
cessing during V(D)J recombination but also leads to general 
DNA DSB repair defects that result in aberrant chromosomal 
rearrangements and genomic instability. Thus, partial loss of Ar-
temis function may predispose to lymphoid or other malignan-
cies in addition to causing combined immunodeficiencies.
MATERIALS AND METHODS
Generation of Artemis-P70 knock-in mice. The targeting construct was 
generated using the pLNTK plasmid (pSalI–loxP-Neor-loxP–XhoI-TK cas-
sette) (43). The 2.5-kbp 5 homology arm and a 2.7-kbp 3 homology arm 
were PCR amplified from R1 mouse ES cell genomic DNA. Both homo-
logy arms were subcloned into pLNTK and fully sequenced. The nucleotide 
changes to introduce the nonsense mutation at aa D449 in the mouse Artemis 
gene were introduced via site-directed mutagenesis (Agilent Technologies) 
and confirmed by sequence analysis. The targeting construct was linearized 
with PvuI and electroporated into 129Sv-derived R1 mouse ES cells. Indi-
vidual ES clones were selected in G418 and counterselected in gancyclovir. 
Homologously targeted recombinants were identified by Southern blotting 
using EcoRV-digested genomic DNA and 5 and 3 genomic probes.
The successfully targeted ES cell lines were subcloned and subsequently 
karyotyped. Two independently derived subclones with normal karyotypes 
were injected into C57BL/6 blastocysts. The resulting chimeras were bred 
to C57BL/6 mice to obtain progeny with germline transmission of the   
Artemis-P70 mutation. The germline Art+/P70-Neo mice were subsequently bred 
to transgenic mice expressing the Cre recombinase from the EIIA promoter 
to delete the LoxP-flanked Neor gene during early embryogenesis. Progeny 
harboring the Neo-deleted mutant Artemis allele were screened by Southern 
blot analyses and then intercrossed to obtain Art+/+, Art+/P70, and ArtP70/P70 
mice. Littermates were used for all experiments. The mice were housed in a 
room dedicated to immunodeficient mice within a specific pathogen-free 
facility. All mouse protocols were approved of by the University Committee 
on Use and Care of Animals at the University of Michigan, an Association 
for Assesment and Accreditation of Laboratory Animal Care, International 
accredited institute.
PCR analysis of IgH and TCR rearrangements. DJH and DJ rear-
rangements in sorted pro- and pre–B cells and purified DN thymocytes, re-
spectively,  were  analyzed  by  PCR  amplification  as  previously  described 
(details in supplemental text) (44, 45). PCR analyses were repeated three 
times on at least two independent samples of genomic DNA. Extrachromo-
somal D2-J1 signal joints were analyzed as previously described (46). PCR 
analyses were repeated three times with two or three independent sets of ge-
nomic thymocyte DNA samples.
LM-PCR amplification of signal and coding ends. Genomic DNA 
isolated  from  sorted  Art+/+,  ArtP70/P70,  and  Art/  DN  thymocytes  was 
treated with T4 DNA polymerase, MBN, or left untreated and then ligated 
to double-stranded DNA linkers as previously described (details in supple-
mental text) (35). The ligation products were then subjected to nested PCR 
amplification reactions using locus-specific primers to detect either signal or 
coding V(D)J ends. The PCR products were electrophoresed through 6% 
polyacrylamide gels, transferred to zeta-probe membrane, and then probed 
with  32P 5 end-labeled locus-specific oligonucleotides. Each experiment JEM VOL. 206, April 13, 2009 
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